Fallbericht
Belimumab for the treatment of systemic lupus erythematosus complicated by refractory extremely severe thrombocytopenia: a case report
Chinese Journal of Dermatology · 14.08.2026
DOI: 10.35541/cjd.20230532 ↗Kurz gefasst
Fallbericht in der Zeitschrift Chinese Journal of Dermatology, online erschienen am 14.08.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Belimumab for the treatment of systemic lupus erythematosus complicated by refractory extremely severe thrombocytopenia: a case report. Chinese Journal of Dermatology. https://doi.org/10.35541/cjd.20230532
Vancouver
Belimumab for the treatment of systemic lupus erythematosus complicated by refractory extremely severe thrombocytopenia: a case report. Chinese Journal of Dermatology. 2026. doi:10.35541/cjd.20230532
BibTeX
@article{euvimed2026,
title = {Belimumab for the treatment of systemic lupus erythematosus complicated by refractory extremely severe thrombocytopenia: a case report},
journal = {Chinese Journal of Dermatology},
year = {2026},
doi = {10.35541/cjd.20230532}
}
EUVIMED